BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Anthony Gonçalvès, Marine Gilabert, Éric François et al. · Annals of Oncology · 2012

Cited by 225 works. doi:10.1093/annonc/mds135 Open-access PDF

Authors

References